Clinical Trials Browser

Suspended × Astrocytoma × pembrolizumab × Clear all

NCT07301268 2026-02-03

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Phase 2 Suspended

Astrocytoma, Glioblastoma, Gliosarcoma